DB
NDRA icon

Danske Bank’s ENDRA Life Sciences NDRA Stock Holding History

Danske Bank’s Portfolio NDRA Stock Details NDRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-3
Closed -$19 – 1426
2024
Q4 		$19 Buy
+3
New +$20 ﹤0.01% 1329
2024
Q3 		– Hold
0
– – – 1589

Other funds holding NDRA

TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Danske Bank's NDRA Position: Q1 2025 in Review

Danske Bank sold out of ENDRA Life Sciences (NDRA) in Q1 2025, closing a stake of 3 shares — an estimated $19 sold.

Danske Bank first reported a position in NDRA in Q4 2024 and held it in 1 quarter. The position peaked at $19 in Q4 2024. 2 funds tracked by Wall St. Rank hold NDRA as of Q1 2025.

  • Danske Bank reported no remaining ENDRA Life Sciences position as of Q1 2025 after selling out during the quarter.
  • Danske Bank sold 3 ENDRA Life Sciences shares in Q1 2025, an estimated $19.
  • Danske Bank first reported a position in ENDRA Life Sciences in Q4 2024 and held it in 1 quarter.
  • Danske Bank's ENDRA Life Sciences position peaked at $19 in Q4 2024.
  • 2 funds tracked by Wall St. Rank held ENDRA Life Sciences as of Q1 2025.

Based on Danske Bank's 13F filing for Q1 2025, filed 18 Dec 2025.